234 related articles for article (PubMed ID: 9659578)
1. Role of the cytosine DNA-methyltransferase and p16INK4a genes in the development of mouse lung tumors.
Belinsky SA
Exp Lung Res; 1998; 24(4):463-79. PubMed ID: 9659578
[TBL] [Abstract][Full Text] [Related]
2. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer.
Belinsky SA; Nikula KJ; Baylin SB; Issa JP
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4045-50. PubMed ID: 8633014
[TBL] [Abstract][Full Text] [Related]
3. Deletion and differential expression of p16INK4a in mouse lung tumors.
Belinsky SA; Swafford DS; Middleton SK; Kennedy CH; Tesfaigzi J
Carcinogenesis; 1997 Jan; 18(1):115-20. PubMed ID: 9054597
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
[TBL] [Abstract][Full Text] [Related]
5. Frequent aberrant methylation of p16INK4a in primary rat lung tumors.
Swafford DS; Middleton SK; Palmisano WA; Nikula KJ; Tesfaigzi J; Baylin SB; Herman JG; Belinsky SA
Mol Cell Biol; 1997 Mar; 17(3):1366-74. PubMed ID: 9032263
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell cycle proteins in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumors.
Sabourin CL; Wang QS; Ralston SL; Evans J; Coate J; Herzog CR; Jones SL; Weghorst CM; Kelloff GJ; Lubet RA; You M; Stoner GD
Exp Lung Res; 1998; 24(4):499-521. PubMed ID: 9659580
[TBL] [Abstract][Full Text] [Related]
7. Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer.
Kraunz KS; Nelson HH; Lemos M; Godleski JJ; Wiencke JK; Kelsey KT
Int J Cancer; 2006 Mar; 118(6):1364-9. PubMed ID: 16184554
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
[TBL] [Abstract][Full Text] [Related]
9. Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice.
Cui X; Wakai T; Shirai Y; Hatakeyama K; Hirano S
Toxicol Sci; 2006 Jun; 91(2):372-81. PubMed ID: 16543296
[TBL] [Abstract][Full Text] [Related]
10. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells.
Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M
Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534
[TBL] [Abstract][Full Text] [Related]
11. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
[TBL] [Abstract][Full Text] [Related]
12. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens.
Pulling LC; Vuillemenot BR; Hutt JA; Devereux TR; Belinsky SA
Cancer Res; 2004 Jun; 64(11):3844-8. PubMed ID: 15172992
[TBL] [Abstract][Full Text] [Related]
13. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ
Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
15. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
16. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.
Suzuki M; Sunaga N; Shames DS; Toyooka S; Gazdar AF; Minna JD
Cancer Res; 2004 May; 64(9):3137-43. PubMed ID: 15126351
[TBL] [Abstract][Full Text] [Related]
17. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
[TBL] [Abstract][Full Text] [Related]
18. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.
Lee YY; Kang SH; Seo JY; Jung CW; Lee KU; Choe KJ; Kim BK; Kim NK; Koeffler HP; Bang YJ
Cancer; 1997 Nov; 80(10):1889-96. PubMed ID: 9366289
[TBL] [Abstract][Full Text] [Related]
19. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.
Belinsky SA; Nikula KJ; Palmisano WA; Michels R; Saccomanno G; Gabrielson E; Baylin SB; Herman JG
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11891-6. PubMed ID: 9751761
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines.
Honoki K; Yoshitani K; Tsujiuchi T; Mori T; Tsutsumi M; Morishita T; Takakura Y; Mii Y
Oncol Rep; 2004 May; 11(5):1025-30. PubMed ID: 15069542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
